GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Crism Therapeutics Corp (LSE:CRTX) » Definitions » Other Operating Expense

Crism Therapeutics (LSE:CRTX) Other Operating Expense : £0.34 Mil (TTM As of Jun. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Crism Therapeutics Other Operating Expense?

Crism Therapeutics's Other Operating Expense for the six months ended in Jun. 2024 was £0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 was £0.34 Mil.

Crism Therapeutics's quarterly Other Operating Expense increased from Jun. 2023 (£0.00 Mil) to Dec. 2023 (£0.34 Mil) but then declined from Dec. 2023 (£0.34 Mil) to Jun. 2024 (£0.00 Mil).

Crism Therapeutics's annual Other Operating Expense declined from Dec. 2021 (£0.63 Mil) to Dec. 2022 (£0.40 Mil) and declined from Dec. 2022 (£0.40 Mil) to Dec. 2023 (£0.37 Mil).


Crism Therapeutics Other Operating Expense Historical Data

The historical data trend for Crism Therapeutics's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Crism Therapeutics Other Operating Expense Chart

Crism Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.63 0.40 0.37

Crism Therapeutics Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.40 - 0.34 -

Crism Therapeutics Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.34 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Crism Therapeutics Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Crism Therapeutics's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Crism Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
Kingston Chambers, P.O. Box 173, Tortola, Road Town, VGB
Crism Therapeutics Corp has developed a drug delivery technology to improve the clinical performance of cancer treatments for solid tumours through the local delivery of chemotherapy drugs. Its product ChemoSeed which is in its clinical trial phase, can be implanted directly into the tumour or the resection margin following the removal of a tumour. The company also provides consultancy and formulation services to its clients assisting them with pharmaceutical formulation and development.

Crism Therapeutics Headlines

No Headlines